Profil Financier
Weng Xianding occupe actuellement le rang #2698 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $1.5 B (-$234 sur 24h).
Weng is the majority shareholder of Shenzhen New Industries Biomedical Engineering, a supplier of clinical instruments.
Weng was the first person to be appointed as representative of China's securities watchdog in the city of Shenzhen back in 1992.
The company was founded in 1995 and is based in the southern Chinese city of Shenzhen.